{"title":"Photoreaction products of extract from the fruiting bodies of Polyozellus multiplex","authors":"Hayato Otsuka, Keiyo Nakai, Emi Shimizu, Takamasa Yamaguchi, Mitsuhisa Yamano, Hiroaki Sasaki, Kiyotaka Koyama, Kaoru Kinoshita","doi":"10.1007/s11418-024-01790-6","DOIUrl":null,"url":null,"abstract":"<div><p>Photochemical reactions are powerful tools for synthesizing organic molecules. The input of energy provided by light offers a means to produce strained and unique molecules that cannot be assembled using thermal protocols, allowing for the production of immense molecular complexity in a single chemical step. Furthermore, unlike thermal reactions, photochemical reactions do not require active reagents such as acids, bases, metals, or enzymes. Photochemical reactions play a central role in green chemistry. This article reports the isolation and structure determination of four new compounds (<b>1</b>–<b>4</b>) from the photoreaction products of the <i>Polyozellus multiplex</i> MeOH ext. The structures of the new compounds were elucidated using MS, IR, comprehensive NMR measurements and microED. The four compounds were formed by deacetylation of polyozellin, the main secondary metabolite of <i>P. multiplex</i>, and addition of singlet oxygen generated by sunlight. To develop drugs for treating Alzheimer’s disease (AD) on the basis of the amyloid cascade hypothesis, the compounds (<b>1</b>–<b>4</b>) obtained by photoreaction were evaluated for BACE1 inhibitory activity. The hydrolysates (<b>5</b> and <b>6</b>) of polyozellin, the main secondary metabolites of <i>P. multiplex</i>, were also evaluated. The photoreaction products (<b>3</b> and <b>4</b>) and hydrolysates (<b>5</b> and <b>6</b>) of polyozellin showed BACE1 inhibitory activity (IC<sub>50</sub>: 2.2, 16.4, 23.3, and 5.3 μM, respectively).</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"547 - 557"},"PeriodicalIF":2.5000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Natural Medicines","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s11418-024-01790-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Photochemical reactions are powerful tools for synthesizing organic molecules. The input of energy provided by light offers a means to produce strained and unique molecules that cannot be assembled using thermal protocols, allowing for the production of immense molecular complexity in a single chemical step. Furthermore, unlike thermal reactions, photochemical reactions do not require active reagents such as acids, bases, metals, or enzymes. Photochemical reactions play a central role in green chemistry. This article reports the isolation and structure determination of four new compounds (1–4) from the photoreaction products of the Polyozellus multiplex MeOH ext. The structures of the new compounds were elucidated using MS, IR, comprehensive NMR measurements and microED. The four compounds were formed by deacetylation of polyozellin, the main secondary metabolite of P. multiplex, and addition of singlet oxygen generated by sunlight. To develop drugs for treating Alzheimer’s disease (AD) on the basis of the amyloid cascade hypothesis, the compounds (1–4) obtained by photoreaction were evaluated for BACE1 inhibitory activity. The hydrolysates (5 and 6) of polyozellin, the main secondary metabolites of P. multiplex, were also evaluated. The photoreaction products (3 and 4) and hydrolysates (5 and 6) of polyozellin showed BACE1 inhibitory activity (IC50: 2.2, 16.4, 23.3, and 5.3 μM, respectively).
期刊介绍:
The Journal of Natural Medicines is an international journal publishing original research in naturally occurring medicines and their related foods and cosmetics. It covers:
-chemistry of natural products
-biochemistry of medicinal plants
-pharmacology of natural products and herbs, including Kampo formulas and traditional herbs
-botanical anatomy
-cultivation of medicinal plants.
The journal accepts Original Papers, Notes, Rapid Communications and Natural Resource Letters. Reviews and Mini-Reviews are generally invited.